Background: There are several prognostic factors in patients with Chronic Obstructive Pulmonary Disease (COPD) that include Forced expiratory volume in one second (FEV1), Body Mass Index (BMI), dyspnea severity, exercise capacity and Pulmonary Hypertension (PH). PH is one of the most important factors. PH pathogenesis in patients with COPD has not been clarified thoroughly and factors such as alveolar hypoxemia, polycythemia, acidosis and pulmonary vessels obstruction have been suggested. The authors assessed some of these contributing factors in smoker and non-smoker patients with COPD. Materials and Methods: This comparative-descriptive study included COPD patients suspected to have cor pulmonale without exacerbation in the last four weeks. Echocardiographic evaluation of Pulmonary Arterial Pressure (PAP) was done and Pulmonary Hypertension (PH) was defined as systolic Pulmonary Arterial Pressure (PAP) greater than 40 mmHg. Complete Blood Count (CBC) and Arterial Blood Gas (ABG) were also studied in all patients. Results: Echocardiography was done for 142 patients who were suspected to have PH and 110 patients had measurable PAP. All of the patients were in stage II -IV of COPD according to GOLD criteria. 90 patients had PH of which 47 were smokers and 43 were non-smokers. In smoker patients, significant correlation between PAP and PaO 2 was seen (r=-0.291, p-value=0.047). But in non-smoker patients, this correlation was absent. A significant correlation between PAP and FEV1 (r=-0.341, P value=0.025) was seen in non-smoker patients. This correlation was absent in smoker patients. There was no correlation between PAP and hemoglobin, hemoglobin and FEV, and also PaO 2 and FEV1 in smoker and non-smoker COPD patients. Conclusion: In non-smoker patients with COPD, degree of pulmonary parenchymal lesions and bronchial obliteration plays a more important role than hypoxia in the pathogenesis of pulmonary hypertension.
INTRODUCTION
The greater is Pulmonary Arterial Pressure (PAP), the more is the number of exacerbations and even the length of hospital stay in these patients (1) (2) (3) . Some recent studies with large study samples have shown that PAP may According to the definition, PH is present when mean PAP is greater than 25 mmHg at rest or 30 mmHg with exercise. Mean PAP should be measured by right heart catheterization. Systolic pulmonary artery pressure is determined by Doppler echocardiography and formerly was accepted as PH when it was greater than 40 mmHg which is equal to a tricuspid regurgitation velocity of 3.0 to 3.5 m/sec (6, 7) . In patients with COPD, an increased incidence of right ventricular involvement may correlate with increasing severity of lung dysfunction. Right ventricular hypertrophy is present in 40 percent of patients with an FEV1 <1.0 L and in 70 percent of those with an FEV1 <0.6 L (8). However, the presence of hypoxemia, hypercapnia, and polycythemia also independently predict the development of right ventricular hypertrophy in COPD, although not as strongly as abnormal pulmonary mechanics (6) . Among these, alveolar hypoxemia is one of the main causes (9) . Many of the patients with COPD and FEV1 less than 50% of predicted have alveolar hypoxemia, but in some patients, alveolar hypoxemia occurs in patients (especially non-smokers) with FEV1 more than 50% of predicted due to pulmonary vascular obliteration.
Elevation of PAP is also observed during exercise, nocturnal desaturation and acute exacerbations in COPD patients (10) .
Most of the patients with COPD have history of cigarette smoking or other inhalational exposure.
However, some patients develop COPD without an obvious risk factor (11, 12) . Clinical manifestation and natural history of COPD is slightly related to its etiology.
In the present study, some of the contributing factors to PH in patients with COPD who are smokers and non-smokers were assessed and compared. in PAP when measured by echocardiography or right heart catheterization in patients with PAP less than 45 mmHg, but when PAP was higher than 45 mmHg, its value was more on echocardiography as compared to right heart catheterization (15) . In the present study, PAP was measured by echocardiography. Majority of the patients were in very severe stages of the disease and mean FEV1 was 27.8% of predicted values. Lower FEV1 might be the other cause of higher measured PAP in these patients.
MATERIALS AND METHODS

Patients
In patients with COPD and pulmonary hypertension without past smoking history, PAP had no significant correlation with PaO 2 , but PAP had a correlation with FEV1. Most of the patients with COPD and severe hypoxemia (PaO2 < 55 mmHg) have PH and in this situation mean PAP has a correlation with PaO 2 . PH is also seen in mild to moderate hypoxemia (PaO 2 > 55mmHg), but in this group PAP has more correlation with FEV1 than PaO 2 (16) . In the present study, oxygenation of non-smoker patients with COPD was higher than smoker patients with COPD and this could be the explanation for these results.
On the other hand, PH was seen at higher FEV1 in non- and hemoglobin was not expected.
CONCLUSION
Several mechanisms have been considered for PH pathogenesis in patients with COPD, but exact mechanism is not clear. In smoker patients with COPD, hypoxemia plays main role but it seems that in non-smoker patients with COPD, degree of pulmonary parenchymal lesions and bronchial obliteration plays a more important role than hypoxia in the pathogenesis of pulmonary hypertension.
